CD4 and cancer: Interestingly, M1 coinjection with cancer cells also resulted in decreased T-reg cell populations in CD4+ cells (Figure 5), which may have been related to IFNg-based macrophage activation and downstream M1–T cell crosstalk through IFNg/IL-12 signaling [100].